BKD vs. OMCL, PHR, AHCO, SLNO, WRBY, IRWD, NVCR, FDMT, VRNA, and GYRE
Should you be buying Brookdale Senior Living stock or one of its competitors? The main competitors of Brookdale Senior Living include Omnicell (OMCL), Phreesia (PHR), AdaptHealth (AHCO), Soleno Therapeutics (SLNO), Warby Parker (WRBY), Ironwood Pharmaceuticals (IRWD), NovoCure (NVCR), 4D Molecular Therapeutics (FDMT), Verona Pharma (VRNA), and Gyre Therapeutics (GYRE). These companies are all part of the "medical" sector.
Brookdale Senior Living (NYSE:BKD) and Omnicell (NASDAQ:OMCL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.
Brookdale Senior Living presently has a consensus price target of $7.50, suggesting a potential upside of 8.54%. Omnicell has a consensus price target of $42.20, suggesting a potential upside of 54.01%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than Brookdale Senior Living.
Omnicell received 27 more outperform votes than Brookdale Senior Living when rated by MarketBeat users. Likewise, 67.77% of users gave Omnicell an outperform vote while only 67.00% of users gave Brookdale Senior Living an outperform vote.
97.7% of Omnicell shares are owned by institutional investors. 1.5% of Brookdale Senior Living shares are owned by insiders. Comparatively, 2.6% of Omnicell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Brookdale Senior Living has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500.
In the previous week, Brookdale Senior Living had 1 more articles in the media than Omnicell. MarketBeat recorded 5 mentions for Brookdale Senior Living and 4 mentions for Omnicell. Brookdale Senior Living's average media sentiment score of 1.03 beat Omnicell's score of 0.67 indicating that Brookdale Senior Living is being referred to more favorably in the media.
Omnicell has a net margin of -1.78% compared to Brookdale Senior Living's net margin of -6.27%. Omnicell's return on equity of 3.43% beat Brookdale Senior Living's return on equity.
Omnicell has lower revenue, but higher earnings than Brookdale Senior Living. Omnicell is trading at a lower price-to-earnings ratio than Brookdale Senior Living, indicating that it is currently the more affordable of the two stocks.
Summary
Omnicell beats Brookdale Senior Living on 12 of the 18 factors compared between the two stocks.
Get Brookdale Senior Living News Delivered to You Automatically
Sign up to receive the latest news and ratings for BKD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BKD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Brookdale Senior Living Competitors List
Related Companies and Tools
